Trial Profile
A Dose Block-randomized, Double-blinded, Placebo-controlled, Single-dose, Dose-escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of HL-032 in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Somatropin (Primary) ; Somatropin (Primary)
- Indications Somatotropin deficiency
- Focus Pharmacokinetics
- Sponsors HanAll Biopharma
- 22 May 2014 New trial record